IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tanaka Capital Management Inc

Q4 2021 Holdings

Filed 2022-02-14 | 53 holdings | $2.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
AmyrisCOM03236M101$10.5K1,941,4410.5%
Corcept Therapeutics(CORT)COM218352102$782.0K39,51934.3%
Catalyst Pharmaceuticals(CPRX)COM14888U101$1.4M213,60963.5%
PreviousPage 2 of 2